Pediatrix Medical (MD)
NYSE Market Closed
Pediatrix Medical Group, Inc. is a physician services company focused on women’s, newborn and pediatric care. The company contracts with hospitals, health systems and other care settings to provide specialist clinicians in areas where round-the-clock expertise is often required. Its services include maternal-fetal medicine for high-risk pregnancies, neonatology for premature and critically ill newborns, pediatric subspecialty care such as cardiology, and anesthesia services connected to surgical and hospital procedures.
The company operates as a single physician services segment, with neonatology and other pediatric subspecialties accounting for the majority of revenue. Pediatrix’s clinicians typically work in neonatal intensive care units, hospital-based specialty departments and outpatient settings linked to pediatric and maternal care. The model allows hospitals to access specialist coverage without building every practice group internally, while giving Pediatrix scale in recruiting, scheduling, clinical operations, billing and compliance.
Pediatrix operates in a healthcare services market shaped by hospital relationships, reimbursement from commercial insurers and government programmes, physician staffing supply, and demand for specialised care. Its business is distinct from a hospital operator or insurer: it is primarily a provider organisation built around professional medical services. The company’s role is particularly important in complex births and newborn care, where neonatal intensive care and maternal-fetal expertise can be central to patient outcomes. For investors, key considerations include patient volumes, payor mix, reimbursement trends, clinician retention and the company’s ability to maintain strong partnerships with hospitals and health systems.
Last updated
- Market Cap
- 1.86B
- P/E
- 10.66
- P/FCF
- 7.82
- P/S
- 0.96
- Enterprise Value
- 2.24B
- Sector
- —
- Industry
- —
- Address
- 1301 CONCORD TERRACE, SUNRISE, FL, 33323
Midland and Probe Gold Resume Work on the Copper-Gold-Silver-Molybdenum Discovery on the La Peltrie Option
Implied Volatility Surging for Pediatrix Medical (MD) Stock Options
Why Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?
Midland and SOQUEM Launch Their 2024 Exploration Campaign in the Labrador Trough, Quebec
Pediatrix (MD) Q1 Earnings Beat on Hospital Contract Fees
Compared to Estimates, Pediatrix Medical Group (MD) Q1 Earnings: A Look at Key Metrics
Midland Amends Its Lithium Option Agreement With Rio Tinto With the Addition of the Wookie Project
Midland Expands Its Land Position for Gold in James Bay With the New Caniapisc Au Project
Midland/Barrick Starts Sonic Drilling Program on Its Patris Gold Property
ICON (ICLR) Up 7.6% Since Last Earnings Report: Can It Continue?
Midland, in Partnership With RTEC, Announces the Launch of a Maiden 5.8M CAD Lithium Drilling Program on Galinée
Pediatrix's (MD) Q4 Earnings Miss Due to Soft Patient Volumes
Pediatrix Medical Group (MD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Simon Lussier Joins Midland’s Board of Directors
Midland Exploration Announces the Grant of Options
Will High Expenses Ail Pediatrix Medical's (MD) Q4 Earnings?
Midland Provides an Overview of Its 2024 Exploration Activities With Its Partners and Also Follow-Up on Its New Discoveries
Midland Confirms High-Grade Lithium Up to 3.6% Li₂O on Additional Spodumene-Bearing Pegmatites on Galinée Project
Midland is ECOLOGO® Certified for Mineral Exploration
Midland and SOQUEM Discover New High-Grade Copper-Gold Showings on Nachicapau in Nunavik
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 1.86B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 2.24B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 10.66
- P/B
P/B ratio compares a company's share price to its book value per share.
- 2.11
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.96
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 8.57
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.16
- EPS
- 2.12
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 7.82
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 7.18
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 237.32M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 19.83%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 8.42%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.67
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.33
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.33
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.46
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 874.05K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 22.61
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 476.2M | 493.77M | 492.88M | 468.84M | 458.36M |
| Gross profit | 476.2M | 493.77M | 492.88M | 468.84M | 458.36M |
| Operating income | 41.66M | 48.79M | 68.05M | 59.87M | 32.1M |
| EBITDA | 52.7M | 60.3M | 79.56M | 69.01M | 44.04M |
| Net income | 29.57M | 33.68M | 71.71M | 39.26M | 20.74M |
| Basic EPS | 0.37 | 0.41 | 0.85 | 0.46 | 0.25 |
| Diluted EPS | 0.36 | 0.4 | 0.84 | 0.46 | 0.24 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 2.07B | 2.25B | 2.2B | 2.1B | 1.99B |
| Total liabilities | 1.19B | 1.38B | 1.31B | 1.27B | 1.2B |
| Total equity | 878.58M | 865.85M | 890.67M | 833.75M | 789.19M |
| Cash & equivalents | 205.78M | 375.24M | 340.06M | 224.73M | 98.98M |
| Current assets | 587.03M | 763.51M | 717.2M | 613.05M | 491.67M |
| Current liabilities | 442.64M | 458.91M | 392.55M | 341.04M | 271.05M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | -129.85M | 114.1M | 137.29M | 137.17M | -117.46M |
| Investing cash flow | -11.98M | -10.28M | 6.6M | -7.15M | -7.46M |
| Financing cash flow | -27.64M | -68.64M | -28.56M | -4.26M | -6.04M |
| Change in cash | -169.46M | 35.18M | 115.33M | 125.75M | -130.96M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| form 4 | Form 4 — ORDAN MARK S | View Filing | |
| form 4 | Form 4 — ORDAN MARK S | View Filing | |
| form 4 | Form 4 — Moore Mary Ann E | View Filing | |
| form 4 | Form 4 — Moore Mary Ann E | View Filing | |
| form 4 | Form 4 — Neeb Don Gregory | View Filing | |
| form 4 | Form 4 — Neeb Don Gregory | View Filing | |
| form 4 | Form 4 — ORDAN MARK S | View Filing | |
| form 4 | Form 4 — ORDAN MARK S | View Filing | |
| form 4 | Form 4 — Rossi Kasandra H | View Filing | |
| form 4 | Form 4 — Rossi Kasandra H | View Filing | |
| edgar index | S-8 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 144 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| form 4 | Form 4 — McEachin Thomas | View Filing | |
| form 4 | Form 4 — McEachin Thomas | View Filing | |
| form 4 | Form 4 — Weis Shirley A | View Filing | |
| form 4 | Form 4 — Weis Shirley A | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| form 4 | Form 4 — Moore Mary Ann E | View Filing | |
| form 4 | Form 4 — Moore Mary Ann E | View Filing | |
| edgar index | 8-K — Pediatrix Medical Group, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — Newman Kurt Douglas | View Filing | |
| form 4 | Form 4 — McEachin Thomas | View Filing | |
| form 4 | Form 4 — McEachin Thomas | View Filing | |
| form 4 | Form 4 — Weis Shirley A | View Filing | |
| form 4 | Form 4 — Weis Shirley A | View Filing | |
| form 4 | Form 4 — Starcher John M. Jr. | View Filing | |
| form 4 | Form 4 — Young Sylvia Jean | View Filing | |
| form 4 | Form 4 — SANSONE GUY P | View Filing | |
| form 4 | Form 4 — Linynsky Laura A | View Filing | |
| form 4 | Form 4 — Rucker Michael A. | View Filing | |
| edgar index | 8-K — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 10-Q — Pediatrix Medical Group, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEFA14A — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | DEF 14A — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | DEFA14A — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | ARS — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| form 4 | Form 4 — Rossi Kasandra H | View Filing | |
| form 4 | Form 4 — Moore Mary Ann E | View Filing | |
| form 4 | Form 4 — Moore Mary Ann E | View Filing | |
| form 4 | Form 4 — Moore Mary Ann E | View Filing | |
| edgar index | 8-K — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 10-K — Pediatrix Medical Group, Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 144 — Pediatrix Medical Group, Inc. | View Filing | |
| form 4 | Form 4 — ORDAN MARK S | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 144 — Pediatrix Medical Group, Inc. | View Filing | |
| form 4 | Form 4 — Rucker Michael A. | View Filing | |
| edgar index | 4 — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 144 — Pediatrix Medical Group, Inc. | View Filing | |
| form 4 | Form 4 — Linynsky Laura A | View Filing | |
| edgar index | 8-K — Pediatrix Medical Group, Inc. | View Filing | |
| edgar index | 10-Q — Pediatrix Medical Group, Inc. | View Filing |